Recently, it has been shown that ETS factors such as ERG markedly increase AR binding in mouse prostate tissue and mediate robust transcriptional changes in PTEN null prostate cancer cells (Chen et al, 2013). The gene discussed is ERG; the disease is prostate carcinoma.